SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (653)7/13/2004 1:53:04 PM
From: nigel bates  Read Replies (1) of 1022
 
Press pretty positive on the Mycograb results.

Planned 2005 launch. The company is planning to hang on to European distribution themselves, and outlicense elsewhere (ceo sensibly wants to control their own destiny on what will be a niche product). ABN Amro is forecasting £124.6m peak sales (I trust this is a translation from a dollar amount, and not an example of spurious accuracy).

Assuming fairly low risk on approval, then they don't look expensive. If Aurograb pans out, then they'll be a lot higher next year....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News